These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 15893495)
1. Identification of a detrimental role for NK cells in pneumococcal pneumonia and sepsis in immunocompromised hosts. Kerr AR; Kirkham LA; Kadioglu A; Andrew PW; Garside P; Thompson H; Mitchell TJ Microbes Infect; 2005 May; 7(5-6):845-52. PubMed ID: 15893495 [TBL] [Abstract][Full Text] [Related]
2. Influence of neutropenia on the course of serotype 8 pneumococcal pneumonia in mice. Marks M; Burns T; Abadi M; Seyoum B; Thornton J; Tuomanen E; Pirofski LA Infect Immun; 2007 Apr; 75(4):1586-97. PubMed ID: 17296760 [TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci. Dessing MC; Florquin S; Paton JC; van der Poll T Cell Microbiol; 2008 Jan; 10(1):237-46. PubMed ID: 17711480 [TBL] [Abstract][Full Text] [Related]
4. Protease activated receptor 4 limits bacterial growth and lung pathology during late stage Streptococcus pneumoniae induced pneumonia in mice. de Stoppelaar SF; Van't Veer C; van den Boogaard FE; Nieuwland R; Hoogendijk AJ; de Boer OJ; Roelofs JJ; van der Poll T Thromb Haemost; 2013 Sep; 110(3):582-92. PubMed ID: 23783078 [TBL] [Abstract][Full Text] [Related]
5. The endothelial protein C receptor impairs the antibacterial response in murine pneumococcal pneumonia and sepsis. Schouten M; de Boer JD; Kager LM; Roelofs JJ; Meijers JC; Esmon CT; Levi M; van 't Veer C; van der Poll T Thromb Haemost; 2014 May; 111(5):970-80. PubMed ID: 24401906 [TBL] [Abstract][Full Text] [Related]
6. Nitric oxide exerts distinct effects in local and systemic infections with Streptococcus pneumoniae. Kerr AR; Wei XQ; Andrew PW; Mitchell TJ Microb Pathog; 2004 Jun; 36(6):303-10. PubMed ID: 15120156 [TBL] [Abstract][Full Text] [Related]
7. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. Rubins JB; Charboneau D; Paton JC; Mitchell TJ; Andrew PW; Janoff EN J Clin Invest; 1995 Jan; 95(1):142-50. PubMed ID: 7814608 [TBL] [Abstract][Full Text] [Related]
8. Pneumococcal behavior and host responses during bronchopneumonia are affected differently by the cytolytic and complement-activating activities of pneumolysin. Jounblat R; Kadioglu A; Mitchell TJ; Andrew PW Infect Immun; 2003 Apr; 71(4):1813-9. PubMed ID: 12654795 [TBL] [Abstract][Full Text] [Related]
9. Amino acid changes affecting the activity of pneumolysin alter the behaviour of pneumococci in pneumonia. Alexander JE; Berry AM; Paton JC; Rubins JB; Andrew PW; Mitchell TJ Microb Pathog; 1998 Mar; 24(3):167-74. PubMed ID: 9514638 [TBL] [Abstract][Full Text] [Related]
10. Detoxified pneumolysin derivative Plym2 directly protects against pneumococcal infection via induction of inflammatory cytokines. Lu J; Sun T; Hou H; Xu M; Gu T; Dong Y; Wang D; Chen P; Wu C; Liang C; Sun S; Jiang C; Kong W; Wu Y Immunol Invest; 2014; 43(7):717-26. PubMed ID: 25020076 [TBL] [Abstract][Full Text] [Related]
11. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Rubins JB; Charboneau D; Fasching C; Berry AM; Paton JC; Alexander JE; Andrew PW; Mitchell TJ; Janoff EN Am J Respir Crit Care Med; 1996 Apr; 153(4 Pt 1):1339-46. PubMed ID: 8616564 [TBL] [Abstract][Full Text] [Related]
12. Granzyme A impairs host defense during Streptococcus pneumoniae pneumonia. van den Boogaard FE; van Gisbergen KP; Vernooy JH; Medema JP; Roelofs JJ; van Zoelen MA; Endeman H; Biesma DH; Boon L; Van't Veer C; de Vos AF; van der Poll T Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L507-16. PubMed ID: 27343190 [TBL] [Abstract][Full Text] [Related]
13. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. Briles DE; Hollingshead SK; Paton JC; Ades EW; Novak L; van Ginkel FW; Benjamin WH J Infect Dis; 2003 Aug; 188(3):339-48. PubMed ID: 12870114 [TBL] [Abstract][Full Text] [Related]
15. Leptin improves pulmonary bacterial clearance and survival in ob/ob mice during pneumococcal pneumonia. Hsu A; Aronoff DM; Phipps J; Goel D; Mancuso P Clin Exp Immunol; 2007 Nov; 150(2):332-9. PubMed ID: 17822444 [TBL] [Abstract][Full Text] [Related]
16. NK and NKT Cell Depletion Alters the Outcome of Experimental Pneumococcal Pneumonia: Relationship with Regulation of Interferon-γ Production. Christaki E; Diza E; Giamarellos-Bourboulis EJ; Papadopoulou N; Pistiki A; Droggiti DI; Georgitsi M; Machova A; Lambrelli D; Malisiovas N; Nikolaidis P; Opal SM J Immunol Res; 2015; 2015():532717. PubMed ID: 26114123 [TBL] [Abstract][Full Text] [Related]
17. PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal Pneumonia. Walker MM; Novak L; Widener R; Grubbs JA; King J; Hale JY; Ochs MM; Myers LE; Briles DE; Deshane J J Immunol; 2016 Mar; 196(5):2239-48. PubMed ID: 26829988 [TBL] [Abstract][Full Text] [Related]
18. Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis. Xu Q; Surendran N; Verhoeven D; Klapa J; Ochs M; Pichichero ME Vaccine; 2015 Feb; 33(8):993-1000. PubMed ID: 25597944 [TBL] [Abstract][Full Text] [Related]